期刊文献+

中西医结合治疗2型糖尿病胃功能紊乱90例 被引量:1

下载PDF
导出
摘要 目的探讨中西医结合治疗2型糖尿病胃功能紊乱的可行性。方法将经临床确诊的2型糖尿病胃功能紊乱170例患者随机分为治疗组90例和对照组80例。2组均予西药治疗,治疗组加用中药治疗,观察2组疗效。结果治疗组治愈80例,好转8例,未愈2例,总有效率为98%;对照组治愈56例,好转12例,未愈12例,总有效率为85%。治疗组疗效优于对照组,2组总有效率比较有显著性差异(P<0.05)。结论中西医结合治疗2型糖尿病胃功能紊乱比单纯西药治疗疗效更加显著,能提高治愈率,降低西药不良反应,达到标本兼治的效果。
出处 《现代中西医结合杂志》 CAS 2011年第29期3695-3696,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献3

二级参考文献16

  • 1Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes,other risk factors, and 12 - yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434 - 444.
  • 2Turner RC, Millns H, Neil HA, Stratton TM, Manley SE,Matthews DR, Holman RR: Risk factors for coronary artery disease in non - insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study(UKPDS 23)BMJ 1998;316:823- 828.
  • 3Collins R, Armitage J, Parish S, Sleigh P, Peto R, the Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol - lowering with simvastin in 5963 people with diabetes: a randomized placebo - controlled trial. Lancet 2003; 361: 2005- 2016.
  • 4Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R: Effect of recombinant Apo1 Milano on coronary atherosclerosis in patients with acute coronary syndromes; a randomized controlled trial. JAMA 2003; 290: 2292 -2300.
  • 5West KM, Ahuja MM, Bennett PH, Czyzyk A, De Acosta OM, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K: The role of circulating glucose and triglyceride concentrations and their interactions with other"risk factors"as determinants of arterial disease in nine diabetic population samples form the WHO multinational study. Diabetes Care 1983; 6: 361 - 369.
  • 6Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, Dandona P:Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear lerkocytes and mononuclear cells. Am J Clin Nutr 2002; 75: 767 - 772.
  • 7Austin MA. Plasma triglyceride as a risk factor for cardiobascular disease. Can J Cardiol 1998; 14:14B- 17B.
  • 8Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, rand LI, Christlieb AR, Bradley RF, Kahn CR: Magnitude and determinants of coronary artery disesase in juvenile - onset, insulin dependent diabetes mellitus. Am J Cardio 1987; 159: 750 - 755.
  • 9Hillier TA, Pedula KL: Complications in youg adults with early - onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 2003 ;26:2999 - 3005.
  • 10Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton - Menys V, Fuller JH, the CARDS Investigators: Primary Primary prebention of cardiovascular disease with atorvastatin in type 2 dibetes in the Collaborative Atorvastatin Diabetes Study(CARDS). multicentre randomized placebo- controlled trial. Lancet 2004;364:685 - 696.

共引文献29

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部